Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase II]

ABSTRACT: Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase II]

PROVIDER: PRJNA494241 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase I]

Project description:Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase I]

| PRJNA494240 | ENA

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

Project description:Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

| PRJNA494239 | ENA

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase II]

Project description:We performed an experiment in humans, in which broad spectrum antibiotics were administered to healthy young adults, prior and subsequent to vaccination with the seasonal influenza vaccine. Transcriptional profiling of peripheral blood mononuclear cells was performed prior to the vaccination and as a time course following the vaccine administration.

2019-09-05 | GSE120718 | GEO

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans [phase I]

2019-09-05 | GSE120717 | GEO

CD4+ T cells exhibit distinct transcriptional phenotypes in the lymph nodes and blood following mRNA vaccination in humans

Project description:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and mRNA vaccination induce robust CD4+ T cell responses. Using single-cell transcriptomics, here, we evaluated CD4+ T cells specific for the SARS-CoV-2 spike protein in the blood and draining lymph nodes (dLNs) of individuals 3 months and 6 months after vaccination with the BNT162b2 mRNA vaccine. We analyzed 1,277 spike-specific CD4+ T cells, including 238 defined using Trex, a deep learning-based reverse epitope mapping method to predict antigen specificity. Human dLN spike-specific CD4+ follicular helper T (TFH) cells exhibited heterogeneous phenotypes, including germinal center CD4+ TFH cells and CD4+IL-10+ TFH cells. Analysis of an independent cohort of SARS-CoV-2-infected individuals 3 months and 6 months after infection found spike-specific CD4+ T cell profiles in blood that were distinct from those detected in blood 3 months and 6 months after BNT162b2 vaccination. Our findings provide an atlas of human spike-specific CD4+ T cell transcriptional phenotypes in the dLNs and blood following SARS-CoV-2 vaccination or infection.

2024-05-31 | GSE249313 | GEO

CHIKV VLP Vaccination in Humans induced broadly neutralizing antibodies

Project description:VLP Vaccination in humans induced antigen-specific B cells with broad reactivity and protection in mouse models of infection

2023-03-31 | GSE218843 | GEO

Systems biology of vaccination for seasonal influenza in humans

Project description:Systems biology of vaccination for seasonal influenza in humans

| PRJNA141363 | ENA

CHIKV VLP Vaccination in Humans induced broadly neutralizing antibodies

Project description:CHIKV VLP Vaccination in Humans induced broadly neutralizing antibodies

| PRJNA905836 | ENA

Beneficial effect of ACI-24 vaccination on microglial phenotypes in an amyloidosis mouse model

Project description:Amyloid-beta (Aβ) deposition is an initiating factor in Alzheimer´s disease (AD). Microglia are the brain immune cells that surround and phagocytose Aβ, but their phagocytic capacity declines in AD. This is in agreement with studies that associate AD risk loci with genes regulating phagocytic function. Immunotherapies are currently pursued as therapeutic strategies against AD and there are increased efforts to understand the role of the immune system in ameliorating AD pathology. Here, we evaluated the effect of the Aβ targeting ACI-24 vaccine in preventing the AD pathology in an amyloidosis mouse model. ACI-24 vaccination elicited a robust and sustained antibody response in APPPS1 mice with an accompanying reduction of Aβ plaque load, amyloid plaque-associated ApoE and dystrophic neurites as compared to non-vaccinated controls. Furthermore, plaque-associated microglia had the tendency to be more activated post vaccination. The lower Aβ plaque load triggered by vaccination with ACI-24 was in concordance with the bulk transcriptomic analysis that revealed a reduction in the expression of several disease-associated microglial signatures. Accordingly, plaque-distant microglia displayed a more ramified morphology, supporting beneficial effects of the vaccination on bulk microglial phenotypes. Our study demonstrates that administration of the Aβ targeting vaccine, ACI-24, triggers protective microglial responses that translate into a reduction of AD pathology suggesting its use as a safe and cost effective AD therapeutic intervention.

2023-01-09 | PXD038665 | Pride

Perturbation of the metabolic phenotypes of vaccination by the gut microbiome in humans

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-09-05 | GSE120719 | GEO